Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuanghuangzhi Capsule for Chronic Cholecystitis (Phase II)
CTR20191571Phase 2Suspended
- Sponsor
- Jilin Yizheng Pharmaceutical Group
- Start
- Aug 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shuanghuangzhi in chronic cholecystitis, sponsored by Jilin Yizheng Pharmaceutical Group. Started Aug 2019; status: suspended.
02
Drugs
Shuanghuangzhi
03
Conditions
chronic cholecystitis
Beyond the preview
Go deeper on CTR20191571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191571.